FDA approves first rapid-acting insulin biosimilar for patients with diabetes
Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...
Ozempic really could blind you - it damages veins in the eye, major study finds
American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic ...
Public News Service on MSN21h
Schools struggle to keep up with diabetes tech, leaving parents to fill gaps
By Phil Galewitz for KFF Health News. Broadcast version by Trimmel Gomes for Florida News Connection reporting for the KFF Health News-Public News Service Collaboration Just a few years ago, children ...
PharmiWeb13h
Medical Device Contract Manufacturing Market: Key Drivers, Challenges, and Opportunities in 2025
The global Medical Device Contract Manufacturing market size was $73.61 billion in 2023 and is projected to reach $81.19 ...